-
Document de presse | 2012.04.18
A new hope in the fight against tuberculosis
Researchers from the Institut Pasteur and Inserm, in collaboration with researchers from the University of Pisa, have uncovered the key role played by specific proteins in the virulence of the mycobacterium responsible for tuberculosis, Mycobacterium tuberculosis. They were able to create an attenuated strain of the mycobacterium, which confers a better protection against tuberculosis than the...
-
Document de presse | 2012.03.11
DENFREE: flying towards the efficient control of dengue
Comfortably nested in the salivary glands of mosquitoes, the dengue virus moves around and infects everybody unlucky enough to be bitten. But on the wings of mosquitoes, it can’t possibly go very far and usually stays within a restricted community… unless it “changes vehicle” and travels further away thanks to the infected humans. Starting in January 2012, the Institut...
-
Document de presse | 2012.02.26
Four Prestigious Awards to Support Innovative Biomedical Research
Sanofi (EURONEXT: SAN and NYSE: SNY) and the Institut Pasteur announced today the creation of the Sanofi-Institut Pasteur Awards to encourage scientific excellence in the service of health. Four hundred and eighty thousand euro (480,000 €) will support four innovative research projects demonstrating real progress in the life sciences and providing answers to major healthcare problems, more...
-
Document de presse | 2012.02.23
New cancer target identified?
A team of researchers from the Institut Pasteur and the CNRS has recently identified a protein that can specifically control the activity of an enzyme whose dysfunction has been linked to the development of several types of cancer. This work reveals a potential therapeutic target for the treatment of certain tumors. This study is being published today in the scientific journal Molecular Cell....
-
Document de presse | 2012.02.13
Europe’s united front against emerging viruses
The new PREDEMICS* project strives to improve current knowledge on certain emerging infectious diseases and develop effective treatment and prevention resources. The European Union will be financing this project to the tune of €11.7 million over a five year period. Coordinated by the Institut Pasteur, this collaborative program unites 17 European research and public health institutions. The...
-
Document de presse | 2012.02.08
New results underline the importance of synaptic genes in autism
Autism has been declared a major national cause for 2012, and will have a high profile in France throughout the whole year. Paradoxically, this syndrome – and its causes in particular – remains poorly understood. A study published on February 9, 2012, in Public Library of Science - Genetics, shows that genetic mutations interfering with communication between neurons are directly...
-
Document de presse | 2012.01.22
Launching of the Institut Pasteur in Laos
Today, Monday January 23, 2012, in Vientiane the launch of the Institut Pasteur in Laos was officiated by the Lao Minister of Public Health, professor Som Ock Kingsadat and the President of the Institut Pasteur in Paris, professor Alice Dautry. This is the Institut Pasteur International Network’s 32nd institute. The new research center for infectious and parasitic diseases aims to reduce...
-
Document de presse | 2011.12.18
Genetic diversity: crucial for our survival in many ways
Thanks to the sequencing of the 27 known human interferon genes, researchers from the Institut Pasteur and the CNRS reconstruct the genetic history of these proteins so central for our immune system, and put forward potentially innovative ways to improve the clinical use of interferons in the treatment of pathologies such as Hepatitis C, multiple sclerosis, and some cancers. These results are...
-
Document de presse | 2011.10.02
Cerebral malaria, allergy-like mechanisms to blame
Researchers from the Institut Pasteur and the CNRS, in collaboration with Inserm and the Université Paris Diderot, have demonstrated the role an inflammatory reaction plays in the development of cerebral malaria in mice. Cerebral malaria is one of the most severe forms of malaria primarily affecting young children. If confirmed in humans, this discovery would pave the way for new therapeutic...
-
Document de presse | 2011.09.12
The first human model for neurodegenerative Sanfilippo syndrome
Researchers from the Institut Pasteur and Inserm, in collaboration with the Centre de Biologie Cellulaire in Lyon, have obtained the first human neuron model for Sanfilippo syndrome, an incurable neurodegenerative disorder that occurs in children. This model is the tool of choice for studying the cellular mechanisms at the root of this disease as well as for identifying therapeutic options....
